NCT04050189View on ClinicalTrials.gov

Validation of the In-utero Transmission of Probiotics

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

April 27, 2022

Primary Completion Date

August 28, 2023

Study Completion Date

November 28, 2023

Conditions
In Utero Drug Exposure
Interventions
BIOLOGICAL

Natural products: Probiotics

Probiotics intake every day (1.5 gram) from 34 weeks of gestation to delivery OR from delivery to 10 days postpartum

OTHER

Placebo

Placebo intake every day (1.5 gram) from 34 weeks of gestation to delivery OR from delivery to 10 days postpartum

Trial Locations (1)

J1H 5N4

CIUSSS de L'Estrie-CHUS Hospital, Sherbrooke

Sponsors
All Listed Sponsors
collaborator

Lallemand Health Solutions

INDUSTRY

lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER